کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1370241 | 981814 | 2011 | 5 صفحه PDF | دانلود رایگان |

The synthesis of a series of benzocoumarin keto-enamine schiff bases is reported. The novel compounds were evaluated for their antihyperlipidemic activity in the hyperlipidemic hamster model. The compound 11 at a dose of 10 mg/kg body weight significantly lowered the plasma triglyceride levels (TG) by 70%, total cholesterol (TC) by 47%, accompanied by an increase in HDL-C/TC ratio by 80% in hyperlipidemic hamsters to a greater degree than the reference drugs atorvastatin and lovastatin.
Figure optionsDownload as PowerPoint slideHighlights
► Synthesis and antidyslipidemic activity of novel benzocoumarins is reported.
► Compound 11 showed better activity than the reference drugs in HFD fed hamsters.
► Dose response studies revealed 25 mg/kg as most optimum dose.
Journal: Bioorganic & Medicinal Chemistry Letters - Volume 21, Issue 22, 15 November 2011, Pages 6709–6713